Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serum gamma-glutamyl transferase measurement
|
108 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||
ESOPHAGEAL CANCER, ALCOHOL-RELATED, SUSCEPTIBILITY TO
|
1 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.700 | 0 | |||||||
HANGOVER, SUSCEPTIBILITY TO (finding)
|
1 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.700 | 0 | |||||||
SUBLINGUAL NITROGLYCERIN, SUSCEPTIBILITY TO POOR RESPONSE TO
|
1 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.700 | 0 | |||||||
Coronary Artery Disease
|
1577 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.100 | 1.000 | 10 | 2010 | 2018 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.090 | 1.000 | 9 | 2009 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.080 | 1.000 | 8 | 2005 | 2016 | ||||
Esophageal carcinoma
|
272 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.080 | 1.000 | 8 | 2001 | 2019 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.080 | 1.000 | 8 | 2005 | 2016 | ||||
Essential Hypertension
|
293 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.070 | 0.857 | 7 | 2007 | 2017 | ||||
Flushing
|
9 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.070 | 1.000 | 7 | 2010 | 2018 | ||||
Malignant neoplasm of stomach
|
615 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.070 | 1.000 | 7 | 2013 | 2018 | ||||
Stomach Carcinoma
|
652 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.070 | 1.000 | 7 | 2013 | 2018 | ||||
Coronary Arteriosclerosis
|
440 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.060 | 1.000 | 6 | 2010 | 2018 | ||||
Hypertensive disease
|
1085 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.060 | 1.000 | 6 | 2014 | 2020 | ||||
Malignant Neoplasms
|
1641 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.050 | 1.000 | 5 | 2006 | 2019 | ||||
Cardiovascular Diseases
|
711 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.040 | 1.000 | 4 | 2015 | 2020 | ||||
Myocardial Infarction
|
680 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.040 | 1.000 | 4 | 2007 | 2014 | ||||
Parkinson Disease
|
990 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.040 | 1.000 | 4 | 2015 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.040 | 1.000 | 4 | 2010 | 2019 | ||||
Dyslipidemias
|
184 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.030 | 1.000 | 3 | 2014 | 2019 | ||||
Liver carcinoma
|
942 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.030 | 1.000 | 3 | 2016 | 2018 | ||||
Acute Chest Syndrome
|
135 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.020 | 1.000 | 2 | 2011 | 2018 | ||||
Acute Coronary Syndrome
|
139 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.020 | 1.000 | 2 | 2011 | 2018 | ||||
Alzheimer's Disease
|
1843 | 0.529 | 0.840 | 12 | 111803962 | missense variant | G/A | snv | 1.9E-02 | 5.8E-03 | 0.020 | 1.000 | 2 | 2016 | 2019 |